158 related articles for article (PubMed ID: 8526840)
1. Oxidative release of nitric oxide accounts for guanylyl cyclase stimulating, vasodilator and anti-platelet activity of Piloty's acid: a comparison with Angeli's salt.
Zamora R; Grzesiok A; Weber H; Feelisch M
Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):333-9. PubMed ID: 8526840
[TBL] [Abstract][Full Text] [Related]
2. Formation of nitric oxide from nitroxyl anion: role of quinones and ferricytochrome c.
Buyukafsar K; Nelli S; Martin W
Br J Pharmacol; 2001 Jan; 132(1):165-72. PubMed ID: 11156574
[TBL] [Abstract][Full Text] [Related]
3. Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion.
Wanstall JC; Jeffery TK; Gambino A; Lovren F; Triggle CR
Br J Pharmacol; 2001 Oct; 134(3):463-72. PubMed ID: 11588100
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, chemistry, and applications of nitroxyl ion releasers sodium trioxodinitrate or Angeli's salt and Piloty's acid.
Hughes MN; Cammack R
Methods Enzymol; 1999; 301():279-87. PubMed ID: 9919577
[No Abstract] [Full Text] [Related]
5. The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms.
Chin KY; Qin C; Cao N; Kemp-Harper BK; Woodman OL; Ritchie RH
Br J Pharmacol; 2014 Apr; 171(7):1722-34. PubMed ID: 24372173
[TBL] [Abstract][Full Text] [Related]
6. Sodium nitrite causes relaxation of the isolated rat aorta: By stimulating both endothelial NO synthase and activating soluble guanylyl cyclase in vascular smooth muscle.
Ling WC; Lau YS; Murugan DD; Vanhoutte PM; Mustafa MR
Vascul Pharmacol; 2015 Nov; 74():87-92. PubMed ID: 26044183
[TBL] [Abstract][Full Text] [Related]
7. Vasorelaxant and antiplatelet activity of 4,7-dimethyl-1,2, 5-oxadiazolo[3,4-d]pyridazine 1,5,6-trioxide: role of soluble guanylate cyclase, nitric oxide and thiols.
Kots AY; Grafov MA; Khropov YV; Betin VL; Belushkina NN; Busygina OG; Yazykova MY; Ovchinnikov IV; Kulikov AS; Makhova NN; Medvedeva NA; Bulargina TV; Severina IS
Br J Pharmacol; 2000 Mar; 129(6):1163-77. PubMed ID: 10725265
[TBL] [Abstract][Full Text] [Related]
8. Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation.
Medana C; Ermondi G; Fruttero R; Di Stilo A; Ferretti C; Gasco A
J Med Chem; 1994 Dec; 37(25):4412-6. PubMed ID: 7996554
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects.
Donzelli S; Fischer G; King BS; Niemann C; DuMond JF; Heeren J; Wieboldt H; Baldus S; Gerloff C; Eschenhagen T; Carrier L; Böger RH; Espey MG
J Pharmacol Exp Ther; 2013 Feb; 344(2):339-47. PubMed ID: 23211362
[TBL] [Abstract][Full Text] [Related]
10. NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries.
Irvine JC; Favaloro JL; Kemp-Harper BK
Hypertension; 2003 Jun; 41(6):1301-7. PubMed ID: 12743008
[TBL] [Abstract][Full Text] [Related]
11. The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.
Sharina IG; Sobolevsky M; Papakyriakou A; Rukoyatkina N; Spyroulias GA; Gambaryan S; Martin E
Br J Pharmacol; 2015 May; 172(9):2316-29. PubMed ID: 25536881
[TBL] [Abstract][Full Text] [Related]
12. Decomposition of Piloty's acid derivatives - Toward the understanding of factors controlling HNO release.
Smulik-Izydorczyk R; Rostkowski M; Gerbich A; Jarmoc D; Adamus J; Leszczyńska A; Michalski R; Marcinek A; Kramkowski K; Sikora A
Arch Biochem Biophys; 2019 Jan; 661():132-144. PubMed ID: 30448388
[TBL] [Abstract][Full Text] [Related]
13. Nitrite directly vasodilates hypoxic vasculature via nitric oxide-dependent and -independent pathways.
Pinder AG; Pittaway E; Morris K; James PE
Br J Pharmacol; 2009 Aug; 157(8):1523-30. PubMed ID: 19594749
[TBL] [Abstract][Full Text] [Related]
14. Role of copper ions and cytochrome P450 in the vasodilator actions of the nitroxyl anion generator, Angeli's salt, on rat aorta.
Nelli S; McIntosh L; Martin W
Eur J Pharmacol; 2001 Feb; 412(3):281-9. PubMed ID: 11166292
[TBL] [Abstract][Full Text] [Related]
15. Piloty's acid derivative with improved nitroxyl-releasing characteristics.
Aizawa K; Nakagawa H; Matsuo K; Kawai K; Ieda N; Suzuki T; Miyata N
Bioorg Med Chem Lett; 2013 Apr; 23(8):2340-3. PubMed ID: 23489625
[TBL] [Abstract][Full Text] [Related]
16. Detection of nitroxyl (HNO) by membrane inlet mass spectrometry.
Cline MR; Tu C; Silverman DN; Toscano JP
Free Radic Biol Med; 2011 May; 50(10):1274-9. PubMed ID: 21349325
[TBL] [Abstract][Full Text] [Related]
17. The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature.
Favaloro JL; Kemp-Harper BK
Cardiovasc Res; 2007 Feb; 73(3):587-96. PubMed ID: 17189622
[TBL] [Abstract][Full Text] [Related]
18. Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donors.
Kenny RG; Ude Z; Docherty JR; Marmion CJ
J Inorg Biochem; 2020 May; 206():110981. PubMed ID: 32088592
[TBL] [Abstract][Full Text] [Related]
19. Ruthenium-nitrite complex as pro-drug releases NO in a tissue and enzyme-dependent way.
Pereira Ade C; Ford PC; da Silva RS; Bendhack LM
Nitric Oxide; 2011 May; 24(4):192-8. PubMed ID: 21440656
[TBL] [Abstract][Full Text] [Related]
20. Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance.
Andrews KL; Lumsden NG; Farry J; Jefferis AM; Kemp-Harper BK; Chin-Dusting JP
Clin Sci (Lond); 2015 Jul; 129(2):179-87. PubMed ID: 25728899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
